Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
4/11/2025
Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
4/11/2025
China Greenlights First Gene Therapy for Hemophilia B
4/10/2025
XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...
4/10/2025
Novartis Files for New Indication of Long-Acting Cholesterol-Lowering ...
4/10/2025
Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...
4/10/2025
ArkBio Completes Phase 3 Trial for AK0901 for ADHD in China
4/9/2025
RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
4/9/2025
China Launches Phase I Trial for Nation's First Monkeypox Vaccine
4/8/2025
Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
4/5/2025
Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
4/1/2025
Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
4/1/2025
Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
4/1/2025
China Accelerates Brain Chip Trials After Initial Success
3/31/2025
Roche's Ocrevus Receives Chinese Approval for MS
3/31/2025
Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...
3/31/2025
BMS's Opdivo and Yervoy Combio Approved in China
3/28/2025
TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
3/28/2025
NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...
3/28/2025
AstraZeneca Advances AZD0120 CAR-T Trial for Lupus
3/28/2025
Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...
3/28/2025
GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...
3/28/2025
Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
3/27/2025
NMPA Approves Suraxavir Marboxil for Influenza Treatment
3/26/2025
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...
3/25/2025
Everest Announces FDA Clearance of IND Application for Tumor-Associate...
3/25/2025
BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
3/24/2025
FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...
3/24/2025
SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...
3/24/2025
GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
3/21/2025
NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China
Page:
1
/
11
Total number of articles:
311
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit